BRD4: a General Regulator of Transcription Elongation

Overview

Journal Transcription

Specialty Molecular Biology

Date 2022 Sep 1

PMID 36047906

Authors

Elisabeth Altendorfer

Yelizaveta Mochalova

Andreas Mayer

Affiliations

Soon will be listed here.

Abstract

Transcription elongation by RNA polymerase II (Pol II) has emerged as a regulatory hub in gene expression. A key control point occurs during early transcription elongation when Pol II pauses in the promoter-proximal region at the majority of genes in mammalian cells and at a large set of genes in . An increasing number of -acting factors have been linked to promoter-proximal pausing. Some factors help to establish the pause, whereas others are required for the release of Pol II into productive elongation. A dysfunction of this elongation control point leads to aberrant gene expression and can contribute to disease development. The BET bromodomain protein BRD4 has been implicated in elongation control. However, only recently direct BRD4-specific functions in Pol II transcription elongation have been uncovered. This mainly became possible with technological advances that allow selective and rapid ablation of BRD4 in cells along with the availability of approaches that capture the immediate consequences on nascent transcription. This review sheds light on the experimental breakthroughs that led to the emerging view of BRD4 as a general regulator of transcription elongation.

Citing Articles

The C-terminal PHDVC5HCH tandem domain of NSD2 is a combinatorial reader of unmodified H3K4 and tri-methylated H3K27 that regulates transcription of cell adhesion genes in multiple myeloma.

Berardi A, Kaestner C, Ghitti M, Quilici G, Cocomazzi P, Li J Nucleic Acids Res. 2024; 53(1.

PMID: 39656918 PMC: 11724302. DOI: 10.1093/nar/gkae1121.

Bromodomain-Containing 4 Is a Positive Regulator of Interleukin-34 Production in the Gut.

Franze E, Laudisi F, Frascatani R, Tomassini L, De Cristofaro E, Stolfi C Cells. 2024; 13(20.

PMID: 39451216 PMC: 11505644. DOI: 10.3390/cells13201698.

CDK9 Inhibition by Dinaciclib Is a Therapeutic Vulnerability in Epithelioid Hemangioendothelioma.

Pobbati A, Burtscher A, Rajaram Siva N, Hallett A, Romigh T, Che K Clin Cancer Res. 2024; 30(18):4179-4189.

PMID: 39052240 PMC: 11398983. DOI: 10.1158/1078-0432.CCR-24-1097.

Biological functions and clinic significance of SAF‑A (Review).

Zhang D, Li L, Li M, Cao X Biomed Rep. 2024; 20(6):88.

PMID: 38665420 PMC: 11040223. DOI: 10.3892/br.2024.1776.

Transcriptional elongation control of hypoxic response.

Soliman S, Iwanaszko M, Zheng B, Gold S, Howard B, Das M Proc Natl Acad Sci U S A. 2024; 121(15):e2321502121.

PMID: 38564636 PMC: 11009653. DOI: 10.1073/pnas.2321502121.

References

Xu L, Chen Y, Mayakonda A, Koh L, Chong Y, Buckley D . Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma. Proc Natl Acad Sci U S A. 2018; 115(22):E5086-E5095. PMC: 5984485. DOI: 10.1073/pnas.1712363115. View

Winter G, Buckley D, Paulk J, Roberts J, Souza A, Dhe-Paganon S . DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation. Science. 2015; 348(6241):1376-81. PMC: 4937790. DOI: 10.1126/science.aab1433. View

Belkina A, Denis G . BET domain co-regulators in obesity, inflammation and cancer. Nat Rev Cancer. 2012; 12(7):465-77. PMC: 3934568. DOI: 10.1038/nrc3256. View

Giono L, Kornblihtt A . Linking transcription, RNA polymerase II elongation and alternative splicing. Biochem J. 2020; 477(16):3091-3104. DOI: 10.1042/BCJ20200475. View

Haberle V, Stark A . Eukaryotic core promoters and the functional basis of transcription initiation. Nat Rev Mol Cell Biol. 2018; 19(10):621-637. PMC: 6205604. DOI: 10.1038/s41580-018-0028-8. View

Custodio N, Carmo-Fonseca M . Co-transcriptional splicing and the CTD code. Crit Rev Biochem Mol Biol. 2016; 51(5):395-411. DOI: 10.1080/10409238.2016.1230086. View

Andrikopoulou A, Liontos M, Koutsoukos K, Dimopoulos M, Zagouri F . Clinical perspectives of BET inhibition in ovarian cancer. Cell Oncol (Dordr). 2021; 44(2):237-249. DOI: 10.1007/s13402-020-00578-6. View

Hou L, Wang Y, Liu Y, Zhang N, Shamovsky I, Nudler E . Paf1C regulates RNA polymerase II progression by modulating elongation rate. Proc Natl Acad Sci U S A. 2019; 116(29):14583-14592. PMC: 6642404. DOI: 10.1073/pnas.1904324116. View

Quaresma A, Bugai A, Barboric M . Cracking the control of RNA polymerase II elongation by 7SK snRNP and P-TEFb. Nucleic Acids Res. 2016; 44(16):7527-39. PMC: 5027500. DOI: 10.1093/nar/gkw585. View

10.

Mandel C, Kaneko S, Zhang H, Gebauer D, Vethantham V, Manley J . Polyadenylation factor CPSF-73 is the pre-mRNA 3'-end-processing endonuclease. Nature. 2006; 444(7121):953-6. PMC: 3866582. DOI: 10.1038/nature05363. View

11.

Jensen T, Jacquier A, Libri D . Dealing with pervasive transcription. Mol Cell. 2013; 52(4):473-84. DOI: 10.1016/j.molcel.2013.10.032. View

12.

Yang Z, Yik J, Chen R, He N, Jang M, Ozato K . Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell. 2005; 19(4):535-45. DOI: 10.1016/j.molcel.2005.06.029. View

13.

Landick R . The regulatory roles and mechanism of transcriptional pausing. Biochem Soc Trans. 2006; 34(Pt 6):1062-6. DOI: 10.1042/BST0341062. View

14.

Jacques C, Lavaud M, Georges S, Tesfaye R, Baudhuin M, Lamoureux F . BET bromodomains' functions in bone-related pathologies. Epigenomics. 2019; 12(2):127-144. DOI: 10.2217/epi-2019-0172. View

15.

Rahnamoun H, Lee J, Sun Z, Lu H, Ramsey K, Komives E . RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation. Nat Struct Mol Biol. 2018; 25(8):687-697. PMC: 6859054. DOI: 10.1038/s41594-018-0102-0. View

16.

Muller F, Tora L . Chromatin and DNA sequences in defining promoters for transcription initiation. Biochim Biophys Acta. 2013; 1839(3):118-28. DOI: 10.1016/j.bbagrm.2013.11.003. View

17.

Connelly S, Manley J . A functional mRNA polyadenylation signal is required for transcription termination by RNA polymerase II. Genes Dev. 1988; 2(4):440-52. DOI: 10.1101/gad.2.4.440. View

18.

Zheng B, Aoi Y, Shah A, Iwanaszko M, Das S, Rendleman E . Acute perturbation strategies in interrogating RNA polymerase II elongation factor function in gene expression. Genes Dev. 2021; 35(3-4):273-285. PMC: 7849361. DOI: 10.1101/gad.346106.120. View

19.

Glover-Cutter K, Kim S, Espinosa J, Bentley D . RNA polymerase II pauses and associates with pre-mRNA processing factors at both ends of genes. Nat Struct Mol Biol. 2007; 15(1):71-8. PMC: 2836588. DOI: 10.1038/nsmb1352. View

20.

Wu S, Lee C, Lai H, Yu C, Lee J, Zuo H . Opposing Functions of BRD4 Isoforms in Breast Cancer. Mol Cell. 2020; 78(6):1114-1132.e10. PMC: 7362310. DOI: 10.1016/j.molcel.2020.04.034. View